1. Erices A., Conget P., Minguell J.J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 2000; 109[1): 235-42
2. Bieback K., Kern S., Kluter H., Eichler H. Critical parametres for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004; 22: 625-34
3. Romanov Y.A., Svintsitskaya V.A., Smimov V.N. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21 [1): 105-10
4. Gallacher L, Murdoch В., Wu D.M. et al. Isolation and characterization of human CD34[-)l_in[-) and CD34[+)l_in[-) hematopoietic stem cells using cell surface markers AC133 and CD7. Blood 2000; 95: 2813-20
5. Aoki M., Yasutake M., Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 2004; 22[6): 994-1002
6. Murohara Т., Ikeda H., Duan J. et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000; 105[11): 1527-36
7. Goodwin H.S., Bicknese A.R., Chien S.N. et al. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol. Blood Marrow Transplant. 2001; 7[11): 581 -8
8. Lee O.K., Kuo Т.К., Chen W.M. et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004; 103[5): 1669-75.
9. Kogler G., Sensken S., Airey J.A. et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 2004; 200 [2): 123-35
10. Sanchez-Ramos J.R., Song S., Kamath S.G. et al. Expression of neural markers in human umbilical cord blood. Exp. Neural. 2001; 171:109 -15
11. Buzanska L, Machaj EX., Zablocka B. et al. Human cord blood derived neurons, astrocytes and oligodendracytes. J. Neurachem. 2001; 78[Suppl. 1): 58
12. Buzanska L, Machaj EX., Zablocka B. et al. Human cord blood-derived cells attain neuronal and glial features in vitro. J. Cell Sci. 2002; 115[Pt. 10): 2131-8
13. Machaj EX., Buzanska L, Gajkowska A. et al. Cord blood derived stem cells differentiates in vitro into neurons, astrocytes and oligodendracytes. Exp. Hematology 2001; 29[Suppl. 1): 4
14. Bicknese A.R., Goodwin H.S., Quinn CO. et al. Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplant. 2002;11[3):261-4
15. Jang Y.K., Park J.J., Lee M.C. et al. Retinoic acid-mediated induction of neurons and glial cells from human umbilical cord-derived hematopoietic stem cells. J. Neurasci. Res. 2004;.75[4): 573-84
16. Fu Y.S., Shih Y.T., Cheng Y.C., Min M.Y. Transformation of human umbilical mesenchymal cells into neurons in vitro. J. Biomed. Sci. 2004; 11: 652-60
17. Jeong J.A., Gang E.J., Hong S.H. et al. Rapid neural differentiation of human cord blood-derived mesenchymal stem cells. Neuroreport. 2004; 15[11): 1731 -4
18. Zigova Т., Song S., Willing A.E. et al. Human umbilical cord blood cells express neural antigens aftertransplantation into the developing rat brain. Cell Transplant. 2002; 11[3): 265-74
19. Goolsby J., Marty M.C, Heletz D. et al. Hematopoietic progenitors express neural genes. Prac. Nat. Acad. Sci. USA 2003; 100[25): 14926-31
20. Tondreau Т., Lagneaux L, Dejeneffe M. et al. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation 2004; 72[7): 319-26
21. Lu P., Blesch A., Tuszynski M.H. Induction of bone marrow stromal cells to neurons: Differentiation, transdifferentiation, or artifact? J. Neurasci. Res. 2004:77:174-91
22. Chen J., Sanberg P.R., Li Y. et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001; 32: 2682
23. Taguchi A., Soma Т., Tanaka H. et al. Administration of CD34+ cells after stroke enhances neuragenesis via angiogenesisin a mouse model. J. Clin. Invest. 2004:114:330-8
24. Willing A.E., Lixian J., Milliken M. et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurasci. Res. 2003; 73[3): 296-307
25. Vendrame M., Cassady J., Newcomb J. et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004; 35: 2390
26. Borlongan C.V., Hadman M., Sanberg CD., Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004; 35: 2385
27. Lu D., Sanberg P.R., Mahmood A. et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat aftertraumatic brain injury. Cell Transplant. 2002; 11 [3): 275-81
28. Newman M.B., Davis CD., Borlongan C.V. et al. Transplantation of human umbilical cord blood cells in the repair of CNS diseases. Expert. Opin. Biol. Ther. 2004; 4[2): 121-30
29. Peterson D.A. Umbilical cord blood cells and brain stroke injury: bringing in fresh blood to address an old problem. J. Clin. Invest. 2004; 114[3): 312-4
30. Kang K.-S., Kim S.W., Oh Y.H. et al. A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy 2005; 7: 368-73
31. Beerheide W., von Mach M.A., Ringel M. et al. Downregulation of b2- microglobulin in human cord blood somatic stem cells after transplantation into livers of SCID-mice: an escape mechanism of stem cells. Biochem. Biophys. Res. Commun. 2002; 294:1052-63
32. Newsome P.N., Johannessen I., Boyle S. et al. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastraenteral. 2003; 124[7): 1891-900
33. Ishikawa F. Transplanted human cord blood cells give rise to hepatocytes in engrafted mice. Ann. N-Y Acad. Sci. 2003; 996:174-85
34. Danet G.H., Luongo J.L, Butler G. et al. C1 qRp defines a new human stem cell population with hematopoietic and hepatic potential. Proc. Nat. Acad. Sci. USA 2002; 99: 10441-5
35. Wang X., Ge S., McNamara G. et al. et al. Albumin-expressing hepatocyte- like cells develop in the livers of immune-deficient mice that received transplants of highly purified human hematopoietic stem cells. Blood 2003; 101 [10): 4201 -8
36. Kakinuma S.,Tanaka Y., Chinzei R. et al. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 2003; 21 [2): 217-27
37. Di Campli C, Piscaglia A.C. et al. A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. Dig. Liver. Dis. 2004; 36[9): 603-13
38. Turrini P., Monego G., Gonzalez J. et al. Human hepatocytes in mice receiving рге-immune injection with human cord blood cells. Biochem. Biophys. Res. Commun. 2005; 326: 66-73
39. Sharma A.D., Cantz Т., Richter R. et al. Human cord blood stem cells generate human cytokeratin 18-negative hepatocyte-like cells in injured mouse liver. Am. J. Pathol. 2005; 167[2): 555-64
40. Nonome K., Li X.K., Takahara T. et al. Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model. Am. J. Physiol. Gastraintest. Liver. Physiol. 2005; 289[6): G1091 -9
41. Kashofer K., Siapati EX., Bonnet D. In vivo formation of unstable heterokaryons following liver da mage and HSC/Progenitor transplantation. Stem Cells. 2005;10;Epub
42. Tanabe Y., Tajima F., Nakamura Y. et al. Analyses to clarify rich fractions in hepatic progenitor cells from human umbilical cord blood and cell fusion. Biochem. Biophys. Res. Commun. 2004; 324[2): 711-8
43. Hong S.H., Gang E.J., Jeong J.A. et al. In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells. Biochem. Biophys. Res. Commun. 2005; 330[4): 1153-61
44. Lee K.D., Kuo Т.К., Whang-Peng J. et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004; 40[6): 1275-84
45. Wang Y., Nan X., Li Y. et al. Induction of umbilical cord blood-derived beta2m-c-Met+ cells into hepatocyte-like cells by coculture with CFSC/HGF cells. Liver Transpl. 2005; 11 [6): 635-43
46. Tang X.P., Yang X., Tan H. et al. Clinical and experimental study on therapeutic effect of umbilical cord blood transplantation on severe viral hepatitis. World J. Gastraenteral. 2003; 9[9):1999-2003
47. Ende N., Chen R., Mack R. NOD/LtJ type 1 diabetes in mice and the effect of stem cells [Berashis) derived from human umbilical cord blood. J. Med. 2002; 33:181-7
48. Ende N., Chen R., Reddi A.S. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem. Biophys. Res. Commun. 2004; 321:168-71
49. Ende N., Chen R., Reddi A.S. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem. Biophys. Res. Commun. 2004; 325: 665-9
50. Ende N., Weinstein F., Chen R., Ende M. Human umbilical cord blood effect on sod mice [amyotraphic lateral sclerosis). Life Sci. 2000; 67[1): 53-9
51. Chen R., Ende N. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotraphic lateral sclerosis in SOD-1 mice. J. Med. 2000; 31:21 -30
52. Garbuzova-Davis S., Willing A.E., Zigova T. et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotraphic lateral sclerosis: distribution, migration, and differentiation. J. Hematother. Stem Cell Res. 2003:12:255-70
53. Ende N., Czameski J., Raveche E. Effect of human cord blood transfer on survival and disease activity in MRL-Lpr/Lpr mice. Clin. Immunol. Immunopath. 1995:75:190-5
54. Soria В., Roche E., Berna G. et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes. 2000; 49[2): 157-62
55. Murohara Т., Ikeda H., Duan J. et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 2000; 1O5[111:1527-36
56. Kim S.Y., Park S.Y., Kim J.M. et al. Differentiation of endothelial cells from human umbilical cord blood AC1 33[-)CD14[+) cells. Ann. Hematol. 2005; 84[7):417-22
57. Yang C, Zhang Z.H., Li Z.J. et al. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb. Haemost. 2004; 91 [6): 1202-21
58. Larrivee В., Karsan A. Isolation and culture of primary endothelial cells. Methods Mol. Biol. 2005; 290: 315-29
59. Aoki M., Yasutake M., Murohara T. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device. Stem Cells 2004; 22[6): 994-1002
60. Ma N., Stamm C, Kaminski A. et al. Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 2005; 66[1): 45-54
61. Botta R, Gao E., Stassi G. et al. Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells. FASEB J. 2004; 18[12): 1392-4
62. Pesce M., Orlandi A., lachininoto M.G. et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circ. Res. 2003;93[5):e51-62
63. Murohara T. Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc. Med. 2001; 11 [8): 303-7
64. Leor J., Guetta E., Feinberg M.S. et al. Human umbilical cord blood-derived CD133+ cells mhance function and repair of the infarcted myocardium. Stem Cells 2005; Oct 6; Epub
65. Kim B.O., Tian H., Prasongsukam K. et al. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circ. 2005; 112[9 Suppl): I96-204
66. Henning R.J., Abu-Ali H., Balis J.U. et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 2004; 13[7-8): 729-39
67. Hirata Y., Sata M., Motomura N. et al. Human umbilical cord blood cells improve cardiac function after myocardial infarction. Biochem. Biophys. Res. Commun. 2005; 327[2):.609-14